SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-20-000013
Filing Date
2020-08-10
Accepted
2020-08-10 16:54:38
Documents
89
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q avdl2020q2.htm   iXBRL 10-Q 2291076
2 EXHIBIT 10.2 exhibit102q22020.htm EX-10.2 89746
3 EXHIBIT 31.1 exhibit311q22020.htm EX-31.1 10240
4 EXHIBIT 31.2 exhibit312q22020.htm EX-31.2 10135
5 EXHIBIT 32.1 exhibit321q22020.htm EX-32.1 5617
6 EXHIBIT 32.2 exhibit322q22020.htm EX-32.2 5626
  Complete submission text file 0001012477-20-000013.txt   9390567

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20200630.xsd EX-101.SCH 52163
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20200630_cal.xml EX-101.CAL 108443
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20200630_def.xml EX-101.DEF 271641
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20200630_lab.xml EX-101.LAB 681752
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20200630_pre.xml EX-101.PRE 432875
12 EXTRACTED XBRL INSTANCE DOCUMENT avdl2020q2_htm.xml XML 1682826
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 201090111
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences